60 Participants Needed

Fatty Acid Diets for Aging

JD
JM
Overseen ByJenna Makarewicz, B.S.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how different types of fatty acids in diets affect brain function in healthy adults aged 65-75. Participants will follow two experimental diets: one high in palmitic acid, common in North American diets, and another high in oleic acid, found in Mediterranean diets (also known as the High Oleic Acid Diet). Each diet lasts for one week, with a balanced low-fat diet in between. Eligible participants are those with normal mental function who are generally healthy and do not have serious health conditions or dietary restrictions. As an unphased trial, this study allows participants to contribute to valuable research on diet and brain health.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on certain medications for cognitive or behavioral issues, hormone replacement therapy, or treatments for certain health conditions like Type 2 Diabetes (unless it's metformin).

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that the High Oleic Acid (HOA) diet often links to good health. Studies indicate that diets rich in oleic acid, a key component of the Mediterranean diet, can lower inflammation markers like Interleukin-6 (IL-6). This suggests the HOA diet could benefit overall health and well-being.

In contrast, the High Palmitic Acid (HPA) diet has shown mixed results. Some studies suggest that reducing palmitic acid can improve brain function and decrease inflammation in older adults. However, diets high in palmitic acid have been linked to increased levels of certain proteins associated with brain changes.

Both diets have been studied in healthy older adults, and no serious safety concerns have been reported. However, the HOA diet generally links to better health outcomes compared to the HPA diet. While both diets are considered safe, the HOA diet might offer more health benefits.12345

Why are researchers excited about this trial?

Researchers are excited about the Fatty Acid Diets for Aging trial because it's exploring how different types of fats in our diets might impact aging. Unlike traditional dietary recommendations that often focus on calorie counting or macronutrient ratios, this trial specifically examines the effects of consuming high oleic acid, a monounsaturated fat prevalent in the Mediterranean diet, and high palmitic acid, a saturated fat common in the American diet. These diets could offer new insights into how specific fats influence aging processes, potentially leading to more tailored dietary guidelines that promote healthier aging. The trial could reveal whether the Mediterranean diet's heart-healthy fats offer distinct benefits over typical saturated fats found in many processed foods.

What evidence suggests that this trial's diets could be effective for brain functioning in aging adults?

This trial will compare the effects of two different diets on aging: the High Oleic Acid Diet (HOA) and the High Palmitic Acid Diet (HPA). Research has shown that the Mediterranean diet, similar to the HOA diet, is high in oleic acid and links to better health. Studies indicate that people who closely follow this diet tend to live longer and have a lower risk of heart disease. Olive oil, a main source of oleic acid, is known for its anti-inflammatory properties and cell protection, which may contribute to longevity.

In contrast, the HPA diet, similar to diets high in palmitic acid often found in the North American diet, can negatively affect brain function and increase inflammation. Research suggests that reducing palmitic acid intake can decrease inflammation and improve brain function in older adults. Overall, the Mediterranean diet, rich in oleic acid, offers promising benefits for aging and brain health.14678

Who Is on the Research Team?

JD

JUlie A Dumas, Ph.D.

Principal Investigator

University of Vermont

CL

Craig L Kien, MD, PhD

Principal Investigator

University of Vermont

Are You a Good Fit for This Trial?

This trial is for healthy older adults aged 65-75 who want to participate in a study on how different fats in the diet affect brain function. Participants will follow strict diets provided by the research team and be closely monitored.

Inclusion Criteria

My BMI is between 20 and 40.
Normal cognition (see Research Strategy for details on cognitive assessments)
I am between 65 and 75 years old.

Exclusion Criteria

Hyper-androgenic condition
I am not on medication for significant cognitive or behavioral issues.
I have Type 2 Diabetes and am treated with drugs other than metformin.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Control Diet

Participants follow a low-fat control diet to balance monounsaturated and saturated fatty acids

2 weeks
2 visits (in-person)

Experimental Diets

Participants follow two experimental diets in a random order: one with a high PA/OA ratio and one with a low PA/OA ratio

2 weeks
2 visits (in-person)

Follow-up

Participants are monitored for changes in working memory performance and brain activation

1 week

What Are the Treatments Tested in This Trial?

Interventions

  • High Oleic Acid Diet
  • High Palmitic Acid Diet
Trial Overview The study tests two diets: one high in palmitic acid, like a typical North American diet, and another high in oleic acid, similar to the Mediterranean Diet. Each participant tries both for one week with a low-fat control diet before each test period.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: High Palmitic Acid Diet (HPA)Experimental Treatment1 Intervention
Group II: High Oleic Acid/Low Palmitic Acid Diet (HOA)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Vermont

Lead Sponsor

Trials
283
Recruited
3,747,000+

Published Research Related to This Trial

A study of 200 hospitalized patients over 60 years old revealed that 91.5% had unhealthy diets, which were linked to poor clinical outcomes like malnutrition and frailty.
Higher adherence to the Mediterranean diet was associated with shorter hospital stays and better overall health, indicating that improving dietary habits could enhance recovery in older adults.
Adherence to the Mediterranean diet in Turkish hospitalized older adults and its association with hospital clinical outcomes.Ergul, F., Sackan, F., Koc, A., et al.[2022]
The European Food Safety Authority has set a Tolerable Daily Intake (TDI) for erucic acid at 7 mg per kg of body weight, but this assessment did not fully account for erucic acid levels in fish and seafood.
Data from the Institute of Marine Research in Norway indicate that consuming a 200 g meal of mackerel could exceed the TDI for erucic acid, contributing up to 143% of the TDI for a 60 kg person, highlighting potential health risks associated with high consumption of certain fish.
Erucic Acid (22:1n-9) in Fish Feed, Farmed, and Wild Fish and Seafood Products.Sissener, NH., Ørnsrud, R., Sanden, M., et al.[2019]
In a study of 60 elderly individuals, those who adhered more closely to the Mediterranean diet (MD) had lower waist-hip ratios and body fat percentages, indicating better nutritional status and potentially lower health risks.
Low adherence to the MD was associated with higher rates of obesity, increased consumption of tobacco and alcohol, and greater cardiovascular risk, highlighting the importance of diet in overall health for the elderly.
[Adherence to the Mediterranean diet and its relation to nutritional status in older people].Zaragoza Martí, A., Ferrer Cascales, R., Cabañero Martínez, MJ., et al.[2016]

Citations

Mediterranean diet component oleic acid decreases ...This study investigates whether nutritional intervention mitigates age-associated systemic impact of oral infection with PD key pathogen Porphyromonas ...
Mediterranean diet and health status: Active ingredients ...A large body of observational and experimental evidence suggests that higher adherence to the MedDiet is associated with lower risk of mortality, cardiovascular ...
Olive Oil and Longevity: A Review of Evidence Linking ...Olive oil, especially EVOO, is linked to reduced mortality and age-related diseases, with antioxidant, anti-inflammatory, and cardioprotective ...
Olive Oil and the Hallmarks of Aging - PMC - PubMed CentralOlive oil targets the hallmarks of aging could explain the improvement of health, reduced risk of aging-associated diseases, and increased longevity.
The Mediterranean Diet and Cardiovascular HealthThe available evidence is large, strong, and consistent. Better conformity with the traditional MedDiet is associated with better cardiovascular health outcomes ...
The effects of the mediterranean diet supplemented with ...We revealed that following an enriched MED with olive oils can reduce Interleukin-6 (IL-6) (SMD: − 1.85; 95% CI: -3.69 to -0.01, I2: 99.29%) and ...
Cardiovascular, Metabolic and Endocrine, Cancer ...Olive oil is proven to be a healthy dietary option for Type 2 diabetes and cardiovascular disease populations, a superior topical application ...
Mediterranean Diet and Quality of Life in AdultsAdherence to the Mediterranean diet provides significant benefits in preventing and managing various chronic diseases commonly associated with aging ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security